Perfil epidemiológico de la enfermedad respiratoria alérgica en niños mexicanos
PDF
XML

Palabras clave

Asthma
Rhinitis
Eczema
Wheezing
Allergy and immunology
Child

Cómo citar

Perfil epidemiológico de la enfermedad respiratoria alérgica en niños mexicanos. (2024). Revista Alergia México, 71(2), 96-107. https://doi.org/10.29262/ram.v71i2.1301

Plaudit

Resumen

Objetivo: Reportar la prevalencia y gravedad de las enfermedades alérgicas más comunes en niños residentes en Monterrey, México.

Métodos: Encuesta multicéntrica transversal, acerca de las enfermedades alérgicas más comunes, completada por padres de niños de 6 aa 7 años y por adolescentes de 13 a 14 años del área metropolitana de Monterrey, entre enero de 2018 y diciembre de 2019.

Resultados: Un total de 3044 cuestionarios fueron elegibles para el análisis. Entre los niños de 6-7 años, 30.2% (n = 143/473) manifestaron sibilancias en algún momento de su vida; con mayor prevalencia en la población masculina. En el grupo de adolescentes el 26.4% refirió haber tenido sibilancias alguna vez en su vida, con un ligero predominio en el grupo femenino (54.9%).

Conclusiones: Conocer la prevalencia de las enfermedades alérgicas en la población brinda herramientas para generar estrategias para la mejor calidad asistencial en los pacientes.

Palabras clave: Asma; Rinitis; Eczema; Sibilancias; Alergia E Inmunología; Niño.

PDF
XML

Referencias

Cecchi L, D'Amato G, Annesi-Maesano I. External exposome and allergic respiratory and skin diseases. J Allergy Clin Immunol 2018; 14 1(3): 846-857. doi: 10.1016/j.jaci.2018.01.016.

Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet 2018; 391 (10122): 783-800. doi: 10.1016/S0140-6736(17)33311-1.

Eghtesad S. Allergic Diseases in the Developing World: An Emerging Problem or an Overseen Issue?. In: Mahdavinia M. (eds) Health Disparities in Allergic Diseases. Springer, Cham. 2020. https://doi.org/10.1007/978-3-030-31222-0_2

Beasley R, Hancox RJ. Reducing the burden of asthma: time to set research and clinical priorities. Lancet Respir Med 2020; 8 (10): 943-944. doi: 10.1016/S2213-2600(20)30400-8.

Asher MI, Stewart AW, Wong G, Strachan DP, et.al. Changes over time in the relationship between symptoms of asthma, rhinoconjunctivitis and eczema: a global perspective from the International Study of Asthma and Allergies in Childhood (ISAAC). Allergol Immunopathol (Madr) 2012; 40 (5): 267-74. doi: 10.1016/j.aller.2011.11.004.

Mallol J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A; ISAAC Phase Three Study Group. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol (Madr) 2013; 41 (2): 73-85. doi: 10.1016/j.aller.2012.03.001.

Ellwood P, Asher MI, Billo NE, Bissell K, et al. The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors. Eur Respir J 2017; 49 (1): 1601605. doi: 10.1183/13993003.01605-2016.

Larenas-Linnemann D, Salas-Hernández J, Vázquez-García JC, Ortiz-Aldana I, et al. Guía Mexicana del Asma: GUIMA 2017 [Mexican Asthma Guidelines: GUIMA 2017]. Rev Alerg Mex 2017; 64 (Suppl 1):s11-s128. doi: 10.29262/ram.v64i0.272.

Ocampo J, Gaviria R, Sánchez J. Prevalencia del asma en América Latina. Mirada crítica a partir del ISAAC y otros estudios [Prevalence of asthma in Latin America. Critical look at ISAAC and other studies]. Rev Alerg Mex 2017; 64 (2): 188-197. doi: 10.29262/ram.v64i2.256.

Aït-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J; ISAAC Phase Three Study Group. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009; 64 (1): 123-48. doi: 10.1111/j.1398-9995.2008.01884.x.

Murrison LB, Brandt EB, Myers JB, Hershey GKK. Environmental exposures and mechanisms in allergy and asthma development. J Clin Invest 2019; 129 (4): 1504-1515. doi: 10.1172/JCI124612.

Del-Río-Navarro BE, Berber A, Reyes-Noriega N, Navarrete-Rodríguez EM, et al. Global Asthma Network Phase I study in Mexico: prevalence of asthma symptoms, risk factors and altitude associations-a cross-sectional study. BMJ Open Respir Res 2020; 7 (1): e000658. doi: 10.1136/bmjresp-2020-000658.

Chinratanapisit S, Suratannon N, Pacharn P, Sritipsukho P, et al. Prevalence and severity of asthma, rhinoconjunctivitis and eczema in children from the Bangkok area: The Global Asthma Network (GAN) Phase I. Asian Pac J Allergy Immunol 2019; 37 (4): 226-231. doi: 10.12932/AP-120618-0336.

Trakultivakorn M, Sangsupawanich P, Vichyanond P. Time trends of the prevalence of asthma, rhinitis and eczema in Thai children-ISAAC (International Study of Asthma and Allergies in Childhood) Phase Three. J Asthma 2007; 44 (8): 609-11. doi: 10.1080/02770900701540119.

Castro A. Childhood asthma from a health equity perspective: The case of Latin America and the Caribbean. Ann Allergy Asthma Immunol 2019; 122 (5): 445-446.e2. doi: 10.1016/j.anai.2019.02.029.

Rao CK, Moore CG, Bleecker E, Busse WW, et al. Characteristics of perimenstrual asthma and its relation to asthma severity and control: data from the Severe Asthma Research Program. Chest 2013; 143 (4): 984-992. doi: 10.1378/chest.12-0973.

Asher MI, García-Marcos L, Pearce NE, Strachan DP. Trends in worldwide asthma prevalence. Eur Respir J 2020; 56 (6): 2002094. doi: 10.1183/13993003.02094-2020.

De la Vega Pazitková T, Pérez Martínez VT, Bezos Martínez L. Relación entre la severidad de las manifestaciones de asma bronquial y el cumplimiento del tratamiento intercrisis. Rev Cuba Med Gen Integ 2011; 27 (3): 294-306.

Jartti T, Bønnelykke K, Elenius V, Feleszko W. Role of viruses in asthma. Semin Immunopathol 2020; 42 (1): 61-74. doi: 10.1007/s00281-020-00781-5.

Altman MC, Beigelman A, Ciaccio C, Gern JE, et al. Evolving concepts in how viruses impact asthma: A Work Group Report of the Microbes in Allergy Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2020; 145 (5): 1332-1344. doi: 10.1016/j.jaci.2019.12.904.

Garcia-Marcos L, Mallol J, Solé D, Brand PL; EISL Study Group. International study of wheezing in infants: risk factors in affluent and non-affluent countries during the first year of life. Pediatr Allergy Immunol 2010; 21 (5): 878-88. doi: 10.1111/j.1399-3038.2010.01035.x.

Levin ME, Botha M, Basera W, Facey-Thomas HE, et al. Environmental factors associated with allergy in urban and rural children from the South African Food Allergy (SAFFA) cohort. J Allergy Clin Immunol 2020; 145 (1): 415-426. doi: 10.1016/j.jaci.2019.07.048.

Meng Y, Wang C, Zhang L. Advances and novel developments in allergic rhinitis. Allergy 2020; 75 (12): 3069-3076. doi: 10.1111/all.14586.

Ojwang V, Nwaru BI, Takkinen HM, Kaila M, et al. Early exposure to cats, dogs and farm animals and the risk of childhood asthma and allergy. Pediatr Allergy Immunol 2020; 31 (3): 265-272. doi: 10.1111/pai.13186.

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.

Derechos de autor 2024 Revista Alergia México

Downloads

Download data is not yet available.